1. Issued in 2014 – SEPHIA

2. SEPHIA Annual report 2013

3. Issued in 2014 – SEPHIA Working group SEPHIA 2013 Chair Kristina Hambraeus, MD, PhD, Falun Gunilla Burell, PhD, Uppsala Åsa Cider, PhD, Gothenburg Lars Eurenius, MD, Stockholm Jan-Erik Karlsson, MD, PhD, Jönköping Margrét Leósdóttir, MD, Malmö Lennart Nilsson, MD, PhD, Linköping Vesna Stefan, RN, Lund Lars Svennberg, MD, Gävle-Sandviken

4. Issued in 2014 – SEPHIA Figure 1. Number of patients per follow-up and year.

5. Issued in 2014 – SEPHIA Figure 2. Number of patients per follow-up year and per hospital.

6. Issued in 2014 – SEPHIA Figure 3. Proportion of patients registered in the target group for follow-up, per year for the 2nd follow-up and per hospital with > 10 patients. Average in 2013 (prevoius years in brackets).

7. Issued in 2014 – SEPHIA Figure 4. Proportion of patients who were smokers at baseline and proportion at the 2nd follow-up, per hospital with > 10 smokers at baseline and 2nd follow-up in 2013.

8. Issued in 2014 – SEPHIA Table 1. Background variables for MI patients admitted to coronary intensive care unit (CICU) from 4th quarter of 2012 to 3rd quarter of 2013 and who are not deseased within 57 days from admission to CICU.

9. Issued in 2014 – SEPHIA Figure 5. Mean LDL level at baseline and at 2nd follow-up, per hospital with > 10 patients at baseline and with 2nd follow-up in 2013.

10. Issued in 2014 – SEPHIA Figure 6. Proportion of patients with BMI > 25 (kg/m 2 ) at CICU and proportion at the 2nd follow-up, per hospital and 2nd follow-up in 2013 with at least 10 individuals with BMI > 25 (kg/m 2 ) at CICU.

11. Issued in 2014 – SEPHIA Figure 7. Proportion of patients with BMI > 30 kg/m 2 at baseline and proportion at 2nd follow-up, per hospital with > 10 patients with BMI > 30 kg/m 2 at baseline and with 2nd follow-up in 2013.

12. Issued in 2014 – SEPHIA Figure 8. Proportion of patients with diabetes at baseline and the proportion at 2nd follow-up, per hospital with > 10 patients with diabetes at baseline and with 2nd follow-up in 2013.

13. Issued in 2014 – SEPHIA Figure 9. Target attainment for patients with diabetes vs. non-diabetes for 2nd follow-up, 2006–2013.

14. Issued in 2014 – SEPHIA Figure 10. Proportion of patients with LDL 10 patients and with 1st follow-up in 2013 (mean value for 2013, previous years in brackets). Patients with > 50 % reduction in LDL compared with baseline are also included.

15. Issued in 2014 – SEPHIA Figure 11. Proportion of patients with LDL 10 patients and with 2nd follow-up in 2013 (mean value for 2013, previous years in brackets). Patients with > 50 % reduction in LDL compared with baseline are also included.

16. Issued in 2014 – SEPHIA Figure 12. Proportion of patients with systolic blood pressure (BP) 10 patients (mean value for 2013, previous years in brackets).

17. Issued in 2014 – SEPHIA Figure 13. Proportion of patients with systolic BP 10 patients (mean value for 2013, previous years in brackets).

18. Issued in 2014 – SEPHIA Figure 14. Proportion of smokers who have quit smoking up to 1st follow up in 2013, per year and hospital with > 10 patients (mean value for 2013, previous years in brackets).

19. Issued in 2014 – SEPHIA Figure 15. Proportion of smokers who have quit smoking up to 2nd follow up in 2013, per year of follow up and per county with > 10 patients (mean value for 2013, previous years in brackets).

20. Issued in 2014 – SEPHIA Figure 16. Proportion of patients who have taken part in a physical exercise programme up to the 1st follow up in 2013, per year and hospital with > 10 patients (mean value for 2013, previous years in brackets).

21. Issued in 2014 – SEPHIA Figure 17. Proportion of patients who have taken part in a physical exercise programme up to the 2nd follow up in 2013, per year of follow up and per hospital with > 10 patients (mean value for 2013, previous years in brackets).

22. Issued in 2014 – SEPHIA Figure 18. Proportion of patients who meet 4 out of 4 (Q4) prevention targets at the 1st follow-up, per year of follow-up and hospital with > 10 patients and where > 50 % of patients in 2013 had complete data needed for Q4. (Target level for LDL < 1.8 mmol/L and apoB < 0.8 g/L). Mean value for 2013, previous years in brackets.

23. Issued in 2014 – SEPHIA Figure 19. Proportion of patients who meet 4 out of 4 (Q4) prevention targets at the 2nd follow-up, per year of follow-up and hospital with > 10 patients and where > 50 % of patients in 2013 had complete data needed for Q4. (Target level for LDL < 1.8 mmol/L and apoB < 0.8 g/L). Mean value for 2013, previous years in brackets.

24. Issued in 2014 – SEPHIA Figure 20. Proportion of patients without chest pain or dyspnoea on the 1st and 2nd follow-up, per year of the patients 1st follow-up, 2006–2013.

25. Issued in 2014 – SEPHIA Figure 21. EQ-VAS (mean) at 1st and 2nd follow-up per age and gender, with > 10 patients in the group, for patients with 2nd follow-up in 2013.

26. Issued in 2014 – SEPHIA Figure 22. EQ-5D index (mean) at 1st and 2nd follow-up per age and gender, with > 10 patients in the group, for patients with 2nd follow-up in 2013.

27. Issued in 2014 – SEPHIA Figure 23. Proportion without symptoms of chest pain/shortness of breath, EQ-VAS (mean) and proportion of readmissions due to non-cardiac or cardiac disease up to 2nd follow-up, for diabetic and non-diabetic patients, 2013.

28. Issued in 2014 – SEPHIA Table 2. The numbers shown signify mean percentage of patients treated with each pharmaceutical agent.

29. Issued in 2014 – SEPHIA Figure 24. Proportion of patients with insulin or oral antidiabetics at 1st follow-up, per year and hospital with > 10 patients (mean value for 2013, previous years in brackets).

30. Issued in 2014 – SEPHIA Figure 25. Proportion of patients with insulin or oral antidiabetics at 2nd follow-up, per year and hospital with > 10 patients (mean value for 2013, previous years in brackets).

31. Issued in 2014 – SEPHIA Figure 26. Proportion of patients with insulin or oral antidiabetics at 1st follow-up in 2012 or 2013, per hospital with > 10 patients receiving pharmacological treatment.

32. Issued in 2014 – SEPHIA Figure 27. Proportion of readmitted patients per cause of readmission and follow-up for patients with 2nd follow-up in 2013.

33. Issued in 2014 – SEPHIA Figure 28. Proportion of readmitted patients at 2nd follow-up per gender and age, for both cardiac and non- cardiac reasons, for patients with 2nd follow-up in 2013.

34. Issued in 2014 – SEPHIA Figure 29. Proportion of patients with and without diabetes who have been readmitted due to cardiac disease up to the 2nd follow-up, per year of follow-up.

35. Issued in 2014 – SEPHIA Figure 30. Proportion of patients previously fit for work on sick leave at 1st follow-up (6–10 weeks after MI), per year of follow-up.

36. Issued in 2014 – SEPHIA Figure 31. Proportion of patients previously fit for work on sick leave at 2nd follow-up (12 months after MI), per year of follow-up.

37. Issued in 2014 – SEPHIA Figure 32. Proportion of patients previously fit for work on full-time sick leave at 1st follow-up in 2013, per year and hospital with > 10 patients. Mean value for 2013, previous years in brackets.